Loyola University Medical Center is the first center in Illinois to implant the CoreValve Evolut R percutaneous aortic heart valve that does not require open heart surgery.

Women and black patients lost more years of their expected life after a heart attack when compared to white men, according to a study published in the Journal of the American College of Cardiology.

Sunshine Heart Inc. announced an update in late July on its COUNTER HF U.S. pivotal study for the C-Pulse Heart Assist System. COUNTER HF is a prospective, randomized, multi-center, controlled study evaluating the safety and efficacy of the C-Pulse system for the treatment of New York Heart Association (NYHA) Class III and ambulatory Class IV heart failure. The study was temporarily paused this past March after the company notified the U.S. Food and Drug Administration (FDA) of four deaths in the treatment arm of the study. The deaths were adjudicated as not device- or therapy-related, and as previously announced on May 26th, the FDA approved resumption of patient enrollment in the study.

Merit Medical Systems Inc. announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) expanding indication for QuadraSphere Microspheres to include the embolization of hepatoma.

Biotronik announced that the first patient has been enrolled in the BioCONTINUE clinical trial (BIOtronik study to assess the CONTINUation of Existing risk of ventricular arrhythmias after CRT-D replacement). BioCONTINUE is the first study to investigate the relevance of defibrillator back-up following first device replacement in a heart failure (HF) patient population with a primary indication for a cardiac resynchronization therapy defibrillator (CRT-D).

corpath, corindus, robotic PCI, robots in the cath lab
Hansen, robotic system, peripheral vascular robot, Magellan
Stereotaxis, Niobe, robotic system, robotic EP ablation
Vijay Iyer, corindus, Corpath, robotic PCI

In the current healthcare economic climate of evaluating “nice vs. necessary” spending for new technology, adoption of robotic catheter navigation systems has its fair share of critics and supporters. Operators already perform procedures manually without robotic assistance, but advocates for the technology point out these systems can greatly improve staff safety by reducing radiation dose and improve outcomes with more accurate procedural navigation. 

The Centers for Medicare & Medicaid Service (CMS) announced that over 2,100 healthcare facilities have agreed to participate in the Bundled Payments for Care initiative to improve care and reduce costs for Medicare. Participants — which include acute care hospitals, skilled nursing facilities, physician group practices, long-term care hospitals, inpatient rehabilitation facilities and home health agencies — have transitioned from a preparatory period to a risk-bearing implementation period in which they assumed financial risk for episodes of care.

The global interventional cardiology devices market is expected to reach $25.16 billion by 2020, according to a new report by Grand View Research. Increasing prevalence of cardiovascular diseases coupled with adoption of minimally invasive surgeries is expected to boost the interventional cardiology device market over the forecast period. Unhealthy lifestyle habits such as high alcohol consumption, smoking and lack of physical exercise are triggering incidences of cardiovascular diseases. Furthermore, the number of congenital heart disease patients is on a constant rise and this acts as a growth driver for the market.

August 14, 2015 — Nonin Medical Inc. announced it has launched the NoninConnect Model 3230 Bluetooth Smart wireless finger pulse oximeter and Apple iOS mobile app to clinicians and patients outside of the United States.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now